# Glucose Homeostasis in Pseudohypoparathyroidism

> **NCT03761290** · — · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Pseudohypoparathyroidism and Pseudopseudohypoparathyroidism
- Pseudohypoparathyroidism Type Ia
- Albright Hereditary Osteodystrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03761290
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-19
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** COVID precautions prevented enrollment of healthy controls, funding ended.
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03761290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03761290, "Glucose Homeostasis in Pseudohypoparathyroidism". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03761290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*